Latest News
|
20 March 2013
1 Likes
US regulators plan to hold a meeting in the coming weeks to address how it communicates risk about regulated products, including how best to communicate adverse event information it receives from its
Read More...
Latest News
|
25 February 2013
0 Likes
Pharmaceutical companies Affymax and Takeda have announced a recall of all lots of their Omontys drug after becoming aware of more than a dozen cases of anaphylaxis, of which three were fatal to
Read More...
Latest News
|
6 February 2013
0 Likes
The US Food and Drug Administration (FDA) is calling for the nomination of new voting members to serve on several of its medical device-related public advisory committees, saying it will accept
Read More...
Latest News
|
29 January 2013
0 Likes
The US Food and Drug Administration (FDA) often courts controversy with its decisions to approve or deny new therapies. In the wake of some high-profile scandals in the past decade, the agency has
Read More...
Latest News
|
3 December 2012
0 Likes
For the second time in as many months, the US Food and Drug Administration (FDA) is calling on the public—and members of the medical device industry, in particular—to nominate new members to one of
Read More...
Latest News
|
12 November 2012
0 Likes
The consumer advocacy group Project on Government Oversight (POGO) is re-engaging the US Food and Drug Administration (FDA) on whether a panel of experts convened by the agency to review the safety of
Read More...
Latest News
|
11 October 2012
0 Likes
An advisory committee meeting convened on behalf of the US Food and Drug Administration (FDA) is set to discuss factors influencing the communication concerning regulated healthcare products,
Read More...
Latest News
|
21 September 2012
0 Likes
The US Department of Health and Human Services (DHHS) is planning to meet in October to discuss whether current protections afforded to human research subjects are adequate, or whether new regulations
Read More...
Latest News
|
10 September 2012
0 Likes
US regulators are calling for new nominees to serve on the US Food and Drug Administration's (FDA) Science Board—an advisory committee charged with providing advice to the agency regarding science and
Read More...
Latest News
|
6 September 2012
0 Likes
Officials at the US Department of Health and Human Services (DHHS) are looking for two new members to serve on the Secretary's Advisory Committee on Human Research Protections (SACHRP), the agency
Read More...